Tue Dec 16 03:30:00 UTC 2025: Summary:

India’s primary market is buzzing with activity today, December 15th, featuring two IPO listings (Wakefit Innovations and Corona Remedies), the second day of bidding for the large ICICI Prudential AMC IPO, and allotment finalizations expected for Park Medi World and Nephrocare Health Services IPOs. Wakefit Innovations’ IPO was subscribed 2.52 times, while Corona Remedies saw massive oversubscription at 137 times. The ICICI Prudential AMC IPO was 72% subscribed on its first day, driven by institutional investors. All eyes will be on the listing performance of Wakefit and Corona Remedies as indicators of investor sentiment.

News Article:

India’s IPO Market Heats Up: Two Listings, Major AMC Issue, and Allotment Dates in Focus

Mumbai, December 15, 2023 – India’s primary market is experiencing a surge of activity today, with investors keenly watching the debut of two new companies, the progress of a major asset management IPO, and the finalization of allotments for two healthcare offerings.

Shares of Wakefit Innovations Ltd and Corona Remedies both made their market debuts today. Wakefit Innovations, whose IPO was subscribed 2.52 times overall, garnered moderate interest, with initial grey market premiums hovering around 2%. Corona Remedies, on the other hand, saw a staggering 137-fold oversubscription. Analysts are closely monitoring Corona Remedies’ performance as an offer-for-sale, to gauge investor confidence in the company’s fundamentals.

Meanwhile, the ICICI Prudential AMC IPO, a significant issue valued at ₹10,603 crore, entered its second day of bidding. The IPO was 72% subscribed on its opening day, fueled by strong institutional investor participation. The offer, entirely an offer-for-sale, closes on December 16th, with listing scheduled for December 19th. Grey market premiums have seen a slight increase, indicating growing investor optimism.

In addition to the listings and active IPO, the market is awaiting the finalization of IPO allotments for Park Medi World and Nephrocare Health Services. Park Medi World’s IPO was subscribed 8.52 times, and Nephrocare Health Services was subscribed over 14 times, driven by strong institutional interest. Allotments for both are expected to be finalized today, with listing scheduled for December 17th.

Today’s flurry of activity will provide key insights into investor risk appetite and market sentiment, particularly the performance of Wakefit and Corona Remedies on their debut. Investors are advised to consult certified experts before making any investment decisions.

Read More